CHR Verviers

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.21825/hctd.88614 Notes sur quelques noms de familie wallons
https://doi.org/10.1055/s-0043-1765674 Are the colonic ESD french results with on-demand double-clip-traction strategy reproducible in other Western centers? Analysis of a Belgian non-academic multicenter registry
https://doi.org/10.1016/j.hansur.2023.09.274 Revue de la littérature des indications, contre-indications et des facteurs influençant les résultats des prothèses trapézo-métacarpiennes
https://doi.org/10.1016/j.anscip.2024.06.183 19. Colistin resistance in pigs – assessing the effectiveness of mitigation measures
https://doi.org/10.21203/rs.3.rs-3973387/v1 Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib – Final 6-year results from a Belgian registry
https://doi.org/10.1007/s10549-024-07275-0 Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium
https://doi.org/10.1055/s-0044-1782906 Impact of annual case volume on colorectal endoscopic submucosal dissection procedural outcomes and safety in a large multicentric prospective cohort study
https://doi.org/10.1055/s-0044-1782735 Diagnostic performance of Japan NBI Expert Team (JNET) classification and CONECCT classification for large colorectal laterally spreading lesions treated by endoscopic submucosal dissection: a large western cohort study
https://doi.org/10.1055/s-0044-1782972 What is the difference in outcomes between the ESD of large colonic and rectal lesions? French multicenter prospective cohort of 3901 procedures (FECCO- NCT04592003)
https://doi.org/10.1055/s-0044-1782959 Outcomes after perforation following colorectal endoscopic submucosal dissection an predictive factors : results from a large prospective multicentric cohort of 4025 procedures
https://doi.org/10.1007/s40200-024-01432-4 The glucose tolerance peak parameter revisited. Definition for a novel use in Gestational Diabetes Mellitus confirmation
https://doi.org/10.37155/2972-4759-2024-02-01-3 Ribociclib plus letrozole alters the blood immune profile in older patients with HR+/HER2- metastatic breast cancer
https://doi.org/10.5194/hess-2024-173 Assessing the long-term effectiveness of nitrogen management for groundwater protection in the agricultural crop production sector in Wallonia, Belgium
https://doi.org/10.5194/hess-2024-173-rc1 Comment on hess-2024-173
https://doi.org/10.5194/hess-2024-173-rc2 Comment on hess-2024-173
[Ventricular aneurism complicating a myocardial infarction].
https://doi.org/10.1055/s-0045-1805614 Technical and oncological outcomes of endoscopic resection of T1 colorectal cancer according to optical diagnosis classification
https://doi.org/10.1055/s-0045-1805208 Analysis of resection margins and prognostic risk factors for T1 colorectal cancers treated by endoscopic submucosal dissection
https://doi.org/10.1055/s-0045-1805291 Prophylactic clipping after colorectal endoscopic submucosal dissection does not reduce delayed bleeding rates: a multicenter propensity-score matched analysis
https://doi.org/10.1055/s-0045-1805293 The « DEBE » score predicts the risk of delayed bleeding after colorectal endoscopic dissection in a large European multicenter cohort
[Diagnostic algorithm of fetal sex discordance in the era of genomic NIPT : clinical illustration and practical recommendation].
https://doi.org/10.1016/j.esmoop.2025.104899 327P A phase IV prospective study of efficacy and safety of Ribociclib and letrozole in first-line in Older women (≥70 years) with hormone receptor-positive HER2-negative advanced Breast cancer: The RibOB study
https://doi.org/10.1016/j.esmoop.2025.104601 47P Serum thymidine kinase activity in older patients with hormone receptor-positive and HER2-negative advanced breast cancer treated with ribociclib and letrozole in the RibOB trial
https://doi.org/10.51821/88.1.13641 Post-transplantation lymphoproliferative disorder (PTLD) with rectal involvement
https://doi.org/10.51821/88.1.13090 Successful Endoscopic Management of Gastric Volvulus: A Case Report Highlighting Effective Treatment Strategies
https://doi.org/10.1002/hon.70093_101 101 | VALEMETOSTAT MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY RESULTS OF THE PHASE 2 VALYM STUDY FROM THE LYSA GROUP
[Intestinal intussusception in adults].
[Dupilumab for eosinophilic esophagitis refractory to standard triple therapy].
[Prolonged fever in an adolescent with a positive blood culture : is it a chronic meningococcemia ?]
https://doi.org/10.1016/j.ijrobp.2025.06.2796 Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines
https://doi.org/10.1016/j.jgo.2025.102397 A prospective study of efficacy and safety of Ribociclib and Letrozole in first line in ≥70 years women with HR-positive advanced breast cancer: RibOB study
https://doi.org/10.1016/j.jgo.2025.102447 Serum thymidine kinase activity in older patients with HR-positive and HER2-negative advanced breast cancer treated with ribociclib and letrozole in the RibOB trial
https://doi.org/10.1016/j.jgo.2025.102374 Biomarker analysis of the RibOB trial: Ribociclib and Letrozole in first line in ≥70 years women with HR-positive HER2-negative advanced breast cancer
https://doi.org/10.1182/blood-2025-1797 Valemetostat monotherapy in patients with relapsed or refractory B-cell lymphoma: Final results of the Phase 2 valym study from the lysa
https://doi.org/10.1016/j.euo.2026.02.007 Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005